Rocket Pharmaceuticals

Kinnari Patel, President, Head of R&D and Chief Operating Officer

Cranbury, N.J.

(NASDAQ: RCKT)

Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Rocket’s multi-platform approach and pipeline of LV hematology and AAV cardiovascular programs allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable people living with devastating rare diseases to experience long and full lives.

www.rocketpharma.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions